Clinical Trial Update: Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin. [Phase 2]

View source ↗

Summary

Phase 2 trial investigating intranasal insulin for Parkinson disease and multiple system atrophy has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy
• Parkinson Disease

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: Peter Novak | Conditions: Parkinson Disease, Multiple System Atrophy | Phase 2 | Status: COMPLETED | Results posted: 2018-11-23